| # | Drug | Count |
|---|---|---|
| 0 | DICLOFENAC | 96 |
| 1 | DICLOFENAC SODIUM | 96 |
| 2 | SULFASALAZINE | 93 |
| 3 | CERTOLIZUMAB PEGOL | 91 |
| 4 | GOLIMUMAB | 91 |
| 5 | RITUXIMAB | 91 |
| 6 | SECUKINUMAB | 91 |
| 7 | ADALIMUMAB-ADAZ | 90 |
| 8 | INFLIXIMAB | 89 |
| 9 | PREDNISONE | 89 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 59 | 0.0309 |
| 1 | GOLD | 63 | 0.0110 |
| 2 | DICLOFENAC POTASSIUM TABLETS | 78 | 0.0093 |
| 3 | CHLORHEXIDINE GLUCONATE | 74 | 0.0081 |
| 4 | DICLOFENAC POTASSIUM | 78 | 0.0073 |
| 5 | PSEUDOEPHEDRINE HCL | 76 | 0.0069 |
| 6 | POVIDONE-IODINE | 28 | 0.0067 |
| 7 | TOFACITINIB CITRATE | 74 | 0.0057 |
| 8 | BOTULINUM TOXIN TYPE A | 67 | 0.0054 |
| 9 | NAPROXEN SODIUM 220MG | 71 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 102 |
| 1 | Corticosteroid [EPC] | 98 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 97 |
| 3 | Aminosalicylate [EPC] | 93 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 91 |
| 5 | Interleukin-17A Antagonist [EPC] | 91 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 88 |
| 7 | Antirheumatic Agent [EPC] | 85 |
| 8 | Vitamin C [EPC] | 84 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 83 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 28 | 0.0065 |
| 1 | Medium-chain Triglyceride [EPC] | 1 | 0.0019 |
| 2 | beta3-Adrenergic Agonist [EPC] | 74 | 0.0016 |
| 3 | Interleukin-5 Antagonist [EPC] | 73 | 0.0015 |
| 4 | Antirheumatic Agent [EPC] | 85 | 0.0008 |
| 5 | Partial Opioid Agonist [EPC] | 67 | 0.0007 |
| 6 | Aminosalicylate [EPC] | 93 | 0.0007 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 68 | 0.0007 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 88 | 0.0007 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 83 | 0.0006 |